Topic of the Month
What dietary news made headlines in 2019?
13 December 2019
Throughout the year, certain nutrition stories surface to grab our attention outside of the traditional news cycle.
06 April 2010
Increased intakes of omega-3 fatty acids in fatty fish may reduce women’s risk of heart failure by about 25 percent, according to a new study.
In the observation study, dietary intakes of 36,234 women aged between 48 and 83 participating in the Swedish Mammography Cohort were analyzed using food-frequency questionnaires (1). Over the course of 18 years of study, 651 cases of heart failure were documented. Eating one serving of fatty fish per week was associated with a 14 percent reduction in the risk of heart failure, compared with women who did not eat any fatty fish.
The benefits appear to be linked to the omega-3 content of the fish, the researchers commented. The highest intake of marine omega-3 fatty acids was linked to a reduction in the risk of heart failure by 25 percent.
The heart health benefits of consuming oily fish, and the omega-3 fatty acids they contain, are well-documented. To date, the polyunsaturated fatty acids (PUFAs) have been linked to improvements in blood lipid levels, a reduced tendency of thrombosis, blood pressure and heart rate improvements, and improved vascular function. Beyond heart health, omega-3 fatty acids, most notably eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have been linked to a wide-range of health benefits, including reduced risk of certain cancers, good development of a baby during pregnancy, joint health, and improved behavior and mood.
13 December 2019
Throughout the year, certain nutrition stories surface to grab our attention outside of the traditional news cycle.
29 June 2013
According to a new US study low blood vitamin K1 concentrations may increase the progression of arterial calcification in people with high blood pressure who take anti-hypertensive medications.
5 December 2011
Vitamin D deficiency and low calcium intakes may be highly prevalent in patients with prostate cancer, says a new Spanish study.